| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission
|
Casolino, Raffaella
|
|
|
24 |
2 |
p. 123-125
|
artikel
|
| 2 |
Adopting shorter radiation regimens: rules of engagement for sarcoma
|
Kalbasi, Anusha
|
|
|
24 |
2 |
p. e70
|
artikel
|
| 3 |
Africa's radiotherapy future gets funding boost
|
Gourd, Elizabeth
|
|
|
24 |
2 |
p. 129
|
artikel
|
| 4 |
Are hemicolectomies justified for appendiceal neuroendocrine tumours smaller than 2 cm?
|
Strosberg, Jonathan R
|
|
|
24 |
2 |
p. 121-122
|
artikel
|
| 5 |
Botswana plans first-ever national cancer control programme
|
Makoni, Munyaradzi
|
|
|
24 |
2 |
p. 127
|
artikel
|
| 6 |
Call to the UK Government for a radical new cancer recovery plan
|
Farron, Tim
|
|
|
24 |
2 |
p. e71
|
artikel
|
| 7 |
Carfilzomib, lenalidomide, and dexamethasone maintenance for multiple myeloma: when and for whom?
|
Engelhardt, Monika
|
|
|
24 |
2 |
p. 118-119
|
artikel
|
| 8 |
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial
|
Dytfeld, Dominik
|
|
|
24 |
2 |
p. 139-150
|
artikel
|
| 9 |
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial
|
Rodler, Eve
|
|
|
24 |
2 |
p. 162-174
|
artikel
|
| 10 |
Correction to Lancet Oncol 2023; 24: 64–76
|
|
|
|
24 |
2 |
p. e72
|
artikel
|
| 11 |
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
|
Chatterji, Subarnarekha
|
|
|
24 |
2 |
p. e74-e85
|
artikel
|
| 12 |
England almost a decade behind on smokefree 2030 target
|
Gourd, Elizabeth
|
|
|
24 |
2 |
p. 130
|
artikel
|
| 13 |
Essential medicines for childhood cancer in Europe
|
Unguru, Yoram
|
|
|
24 |
2 |
p. e67
|
artikel
|
| 14 |
Firefighters at increased risk of cancer diagnosis
|
Gourd, Elizabeth
|
|
|
24 |
2 |
p. e73
|
artikel
|
| 15 |
18F-NaF PET–CT versus 99mTc SPECT in bone metastasis assessment
|
Wang, Jiazheng
|
|
|
24 |
2 |
p. e68
|
artikel
|
| 16 |
18F-NaF PET–CT versus 99mTc SPECT in bone metastasis assessment – Authors' reply
|
Bénard, François
|
|
|
24 |
2 |
p. e69
|
artikel
|
| 17 |
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study
|
Nesti, Cédric
|
|
|
24 |
2 |
p. 187-194
|
artikel
|
| 18 |
Indonesia launches three programmes to boost cancer care
|
Das, Manjulika
|
|
|
24 |
2 |
p. 131
|
artikel
|
| 19 |
International Radiation Oncology societies Network (IRON): a unified voice in addressing global cancer challenges
|
Slotman, Ben J
|
|
|
24 |
2 |
p. 125-126
|
artikel
|
| 20 |
Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment?
|
Bandini, Marco
|
|
|
24 |
2 |
p. e65
|
artikel
|
| 21 |
Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment? – Authors' reply
|
Papachristofilou, Alexandros
|
|
|
24 |
2 |
p. e66
|
artikel
|
| 22 |
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study
|
Wang, Jingyuan
|
|
|
24 |
2 |
p. 151-161
|
artikel
|
| 23 |
National crises and cancer control: challenges for Latin America and beyond
|
The Lancet Oncology,
|
|
|
24 |
2 |
p. 117
|
artikel
|
| 24 |
New collaborating centres in sub-Saharan Africa to improve cancer data access
|
Das, Manjulika
|
|
|
24 |
2 |
p. 128
|
artikel
|
| 25 |
New partnership to boost UK cancer vaccine research
|
Samarasekera, Udani
|
|
|
24 |
2 |
p. 132
|
artikel
|
| 26 |
On a precipice: the UK's broken health-care system
|
Collingridge, David
|
|
|
24 |
2 |
p. 122-123
|
artikel
|
| 27 |
Pharmaceutical industry relationships with oncologists in sub-Saharan Africa
|
Rubagumya, Fidel
|
|
|
24 |
2 |
p. e96-e101
|
artikel
|
| 28 |
Pseudoprogression of a cutaneous lung cancer metastasis
|
Dong, Yue-Mei
|
|
|
24 |
2 |
p. e102
|
artikel
|
| 29 |
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
|
Sherman, Eric J
|
|
|
24 |
2 |
p. 175-186
|
artikel
|
| 30 |
Randomised controlled trials are feasible in anaplastic thyroid cancer
|
Lamartina, Livia
|
|
|
24 |
2 |
p. 119-121
|
artikel
|
| 31 |
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group
|
Piccinin, Claire
|
|
|
24 |
2 |
p. e86-e95
|
artikel
|
| 32 |
Thank you to The Lancet Oncology's reviewers in 2022
|
The Lancet Oncology Editors,
|
|
|
24 |
2 |
p. e58-e64
|
artikel
|
| 33 |
UK cancer care: a watershed moment and the need for urgent intervention
|
Price, Pat
|
|
|
24 |
2 |
p. 133-138
|
artikel
|
Tijdschrift beschrijving